Company / Income Tax
Aurinia Pharmaceuticals Inc. Income Tax History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$173.0M
FY2025
5-year range
-$173.0M / $1.7M
FY2021-FY2025
Trend
-10303.1%
vs FY2024
Sector context
#198 of 204
Health Care
What the data says
Income Tax changed -10303% YoY in FY2025, a notable deviation from the 7-year average annual change of -1341%.
Based on SEC 10-K filings.
-$173M in FY2025.
Improved from $551,000 to -$173M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 204This company -$173.0M Sector average $118.7M
▼
-245.7% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 10303.1% year-over-year.
- Ranks #198 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$173.0M | -10303.1% |
| FY2024 | $1.7M | +207.8% |
| FY2023 | $551.0K | +686.2% |
| FY2022 | -$94.0K | -165.3% |
| FY2021 | $144.0K | +253.2% |
| FY2020 | -$94.0K | -165.3% |
| FY2019 | $144.0K | +97.3% |
| FY2018 | $73.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026